日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

上皮性卵巢癌中苗勒氏管抑制物质 II 型和候选 I 型受体的模式

Basal E, Ayeni T, Zhang Q, Langstraat C, Donahoe P K, Pepin D, Yin X, Leof E, Cliby W

Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor

转化生长因子β受体信号传导和内吞作用通过I型受体中的羧基末端激活基序联系起来。

Garamszegi, N; Doré, J J Jr; Penheiter, S G; Edens, M; Yao, D; Leof, E B

Analysis of Pneumocystis carinii introns

卡氏肺囊虫内含子分析

Thomas, C F Jr; Leof, E B; Limper, A H

Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest

转化生长因子β1抑制p34cdc2磷酸化和组蛋白H1激酶活性与G1/S期生长停滞相关。

Howe, P H; Draetta, G; Leof, E B

Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta

转化生长因子-β对A549人肺癌细胞中尿激酶型纤溶酶原激活剂的合成和活性的调控

Keski-Oja, J; Blasi, F; Leof, E B; Moses, H L